ProfileGDS5822 / ILMN_2708599
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 98% 98% 98% 99% 98% 98% 98% 98% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1413198
GSM1276600PDAC Late Ablation Control 23301.898
GSM1276601PDAC Late Ablation Control 32911.998
GSM1276602PDAC Late Ablation 13910.399
GSM1276603PDAC Late Ablation 23785.598
GSM1276604PDAC Late Ablation 34184.498
GSM1303940PDAC Late Ablation_anti-CTLA4 1380898
GSM1303941PDAC Late Ablation_anti-CTLA4 23268.898
GSM1303942PDAC Late Ablation_anti-CTLA4 33905.498